~~<i id='87A94596BC'><strike id='87A94596BC'><tt id='87A94596BC'><pre id='87A94596BC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：hotspot 2025-09-29 21:29:13 - browse：85

It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： N.Y. state detects polio case, first in the U.S. since 2013

Wikipedia

hotspot

focus

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

WSS

What does generative AI mean for health care? We asked experts

Living with Fabry disease, a condition that causes chronic pain

NIH fellows want a pay raise. Will that mean less money for grants?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Retired US general questions alleged Putin, Prigozhin meeting

Sports medicine is finally prioritizing gender equality

focus

comprehensive

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

Hepatitis C has a cure — but many Americans still lack access to it

Activists slam private health insurers over coverage restrictions

Peter Hotez and the public health issue of online harassment

Supreme Court strikes down use of affirmative action

Study: Pain burden is higher in Black NFL players than white ones

Moonlake's readout produced a cash windfall. Risks remain

Dobbs anniversary: the lost opportunity of abortion as health care

Medical records are filled with copy

Palantir health business leans on meeting customers’ needs

Wikipedia

Heart attack and stroke risk calculators need revising

Iowa House, Senate pass 6

Palantir health business leans on meeting customers’ needs

Elizabeth Holmes on track for early release from her 11

New research casts further doubt on a common procedure used with IVF

Why 40% Americans with Parkinson’s don’t see a neurologist

hotspot

hotspot

focus

focus